about
Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrainSleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography studyAssociation of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.5-HT2A receptor density is decreased in the at-risk mental state.Sleep deprivation increases cerebral serotonin 2A receptor binding in humansSleep deprivation increases A(1) adenosine receptor density in the rat brainRecovery sleep after extended wakefulness restores elevated A1 adenosine receptor availability in the human brain.Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.Chronic sleep restriction induces long-lasting changes in adenosine and noradrenaline receptor density in the rat brain.In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688.Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.Simplified quantification of cerebral A1 adenosine receptors using [18F]CPFPX and PET: analyses based on venous blood sampling.Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: an equilibrium approach.Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease.Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy.Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release.Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.Performance impairment during four days partial sleep deprivation compared with the acute effects of alcohol and hypoxia.Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis.Reestablishment of individual sleep structure during a single 14-h recovery sleep episode after 58 h of wakefulness.Neurotransmitter receptor availability in the rat brain is constant in a 24 hour-period.Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain.Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET.Effects of nocturnal aircraft noise on cognitive performance in the following morning: dose-response relationships in laboratory and field.Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PET.Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans.Partial sleep deprivation: impact on the architecture and quality of sleep.A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humans.Test-retest stability of cerebral mGluR₅ quantification using [¹¹C]ABP688 and positron emission tomography in rats.Oxytocin enhances attractiveness of unfamiliar female faces independent of the dopamine reward system.[¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experiments.Adenosine A(1) receptors in human brain and transfected CHO cells: Inhibition of [(3)H]CPFPX binding by adenosine and caffeine.Determination of the plasma input function of [18F]altanserin by selective liquid–liquid extraction. Validation of a TLC method and comparison to HPLCMetabolism of the A1 adenosine receptor PET ligand [18F]CPFPX by CYP1A2: implications for bolus/infusion PET studiesReproducibility of cerebral A1 adenosine receptor equilibrium modeling using [18F]CPFPX and PETCognitive impairments by alcohol and sleep deprivation indicate trait characteristics and a potential role for adenosine A receptorsReproducibility of Non-Invasive A1 Adenosine Receptor Quantification in the Rat Brain Using [18F]CPFPX and Positron Emission TomographyImaging of Adenosine ReceptorsG15 Switch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington disease: a PET study
P50
Q23761303-C7AD13AB-6767-47D7-A706-8B8044431F05Q28290668-328BE406-094B-498F-A126-F3ED64435B8EQ34499277-00DFB8F6-50D2-48F1-9512-D80E56D6E87AQ34694260-B0025104-8558-41D3-8C7B-E2916AF0F216Q36375242-92562F42-DE7C-47BA-A02B-7A2F4CA729EFQ36759138-FDCC7741-C844-4CC5-9781-8A1140D50358Q38857476-83E3B2E8-F807-4A02-852F-84AC71ABB7D8Q40207601-CB8142C7-C9D3-4D29-9FF6-F48BB4C9CC18Q41032052-DCA1E2BB-77DA-460A-AB89-8DEC48E65DA1Q41988368-B1BAF4DF-DBAB-4311-9E6C-EA7370B3396DQ44648588-E12C575E-4388-4ABD-9FAA-563E86A0E890Q45237175-446F1D07-0614-4F23-B702-66529176B6B6Q45238230-9F5BCE35-137E-4B9D-872D-30078DC2C1AFQ45297840-FA00A3F5-8732-44E0-AC10-317953864E20Q46057234-5ECE604C-C36E-44F3-B07E-10C9828E0E53Q46182958-9991B8E8-A51E-4897-A919-7E17880AD68BQ46676993-0B276FD4-0280-4F6A-9520-D3EEE3A4DADBQ46752753-076807EA-2380-48C4-A68A-433C1D7A25BCQ46901562-A410A46B-5866-488E-A4C7-6E3C421C1F76Q47600374-DB4A803C-D44E-4CA1-9469-B2245B537192Q47726848-22F6DD22-917B-4B1A-A024-FB58092E7592Q47841755-0ECCC225-3FE0-493E-80B2-035C374D154EQ48301045-FDA6F6F8-E4FD-444C-A49C-B7C7F13B852AQ48371780-30862178-59A0-4666-88FB-ADF80678163CQ48381667-FCB54267-EE18-4E4C-A0D4-7C759F8A3010Q48415054-84EF4A5E-FBFC-4A5F-9879-B32741B448ACQ48454863-67D47F44-6ED0-4247-BBBD-4AC1F3DEAAF4Q48484354-EC313466-48FF-4E04-BDB8-707C0A63C5F9Q48683709-0E955F90-C43F-4199-B3E4-E753A30F0781Q48847773-62D09887-C0CE-4FCD-AF6E-14D3A8237479Q48938650-D76D12DA-616A-4505-9D44-911E032A1D78Q50933660-4628F613-5656-4A17-A348-33F1F46DBDD6Q51770953-7370D10F-C600-47BA-91B1-C5D31B8B7FE0Q57515506-F5FEF07D-434E-429E-93BB-CD3B9AB4B71EQ57515525-29B74C91-68A5-41BD-8C49-D4F750E820F4Q57515538-CE7AAAF8-D6E9-4377-AD28-CC76C97D6B06Q57517749-61A50AA0-ECC0-4F88-B584-5ADAE8AD0E48Q57517754-15374C1B-2CFA-4D67-9655-41BE9A5AA3F2Q57517757-20F8D62F-C26C-4346-B07D-AF4C941B593AQ57517761-D66B3A25-C855-4C65-B6A1-A8E02D825DB5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Elmenhorst
@ast
David Elmenhorst
@en
David Elmenhorst
@es
David Elmenhorst
@nl
David Elmenhorst
@sl
type
label
David Elmenhorst
@ast
David Elmenhorst
@en
David Elmenhorst
@es
David Elmenhorst
@nl
David Elmenhorst
@sl
prefLabel
David Elmenhorst
@ast
David Elmenhorst
@en
David Elmenhorst
@es
David Elmenhorst
@nl
David Elmenhorst
@sl
P1053
H-5912-2013
P106
P1153
6506614607
P21
P31
P3829
P496
0000-0001-6137-416X